The new case, in a Michigan farmworker, did not suggest that bird flu was widespread in people, health officials said, adding that the risk to the general public remained low.
Category: Food and Drug Administration
-
Setback Deals Blow to Neuralink’s First Brain Implant Patient, but He Stays Upbeat
Elon Musk’s first human experiment with a computerized brain device developed significant flaws, but the subject, who is paralyzed, has few regrets.
-
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
-
Pasteurized Dairy Foods Free of Live Bird Flu, Federal Tests Confirm
But the scope of the outbreak among cattle remains uncertain, and little human testing has been done.
-
Walnuts Recalled From Natural Food Stores After E. Coli Outbreak
The outbreak linked to shelled organic walnuts distributed by Gibson Farms has sickened 12 people and hospitalized seven in California and Washington State, federal officials said.
-
CPAP Lawsuits Settled for $1.1 Billion
Thousands of people with sleep apnea and other illnesses had sued the company, claiming flawed devices were harming them.
-
Biden Delays Ban on Menthol Cigarettes
The proposal had been years in the making, in an effort to curb death rates of Black smokers targeted by Big Tobacco. In an election year, the president’s worries about support among Black voters may have influenced the postponement.
-
One in Five Milk Samples Nationwide Shows Genetic Traces of Bird Flu
There is no evidence that the milk is unsafe to drink, scientists say. But the survey result strongly hints that the outbreak may be widespread.
-
FDA Approves Antibiotic to Treat Urinary Infections
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
-
Bird Flu Outbreak in Cattle May Have Begun Months Earlier Than Thought
A single spillover, from a bird to a cow, led to the infections, a review of genetic data has found.
-
FDA Issues Alert on Heart Pump Linked to Deaths
The agency faulted the device maker for delayed notice of mounting complications, citing increasing reports of how use of the device perforated the walls of the heart.
-
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.